INTRODUCTION: Key populations, including men who have sex with men, transgender people, sex workers, people who inject drugs, and incarcerated populations, experience high burdens of HIV and urgently need effective interventions. Yet the evidence base for implementation research (IR) with key populations remains weak and poses specific challenges to epidemiologic inference. We apply the Consolidated Framework for IR to consider specific challenges and recommendations for IR with key populations. DISCUSSION: Individuals within key populations exist within inner and outer settings-including organizational structures, legal (eg, criminalization), and funding environments-which influence the design, adoption and fidelity of interventions, and the potential sustainability of intervention scale-up. Underlying vulnerabilities and external stressors experienced at the individual level (eg, homelessness, violence) further impact participation and retention in IR. Thus, researchers should account for representation in the research process, beginning with community engagement in IR design and consideration of enumeration/sampling methods for key populations who lack probabilistic sampling frames. Interventions for key populations require substantial adaptation and complexity (eg, individually tailored, multicomponent) to ensure appropriateness; however, there is tension between the need for complexity and challenges to internal validity (fidelity) and external validity (generalizable scale-up). Finally, integrating contextual, sampling, and implementation elements into analytic approaches is critical for effectiveness evaluation. CONCLUSIONS: Translation of efficacious findings at the individual level to effectiveness at the population level requires recognition of risk heterogeneity. Recognizing the nuances of working with key populations is essential to ensure that individuals are represented by design and therefore gains in population health can be achieved.
INTRODUCTION: Key populations, including men who have sex with men, transgender people, sex workers, people who inject drugs, and incarcerated populations, experience high burdens of HIV and urgently need effective interventions. Yet the evidence base for implementation research (IR) with key populations remains weak and poses specific challenges to epidemiologic inference. We apply the Consolidated Framework for IR to consider specific challenges and recommendations for IR with key populations. DISCUSSION: Individuals within key populations exist within inner and outer settings-including organizational structures, legal (eg, criminalization), and funding environments-which influence the design, adoption and fidelity of interventions, and the potential sustainability of intervention scale-up. Underlying vulnerabilities and external stressors experienced at the individual level (eg, homelessness, violence) further impact participation and retention in IR. Thus, researchers should account for representation in the research process, beginning with community engagement in IR design and consideration of enumeration/sampling methods for key populations who lack probabilistic sampling frames. Interventions for key populations require substantial adaptation and complexity (eg, individually tailored, multicomponent) to ensure appropriateness; however, there is tension between the need for complexity and challenges to internal validity (fidelity) and external validity (generalizable scale-up). Finally, integrating contextual, sampling, and implementation elements into analytic approaches is critical for effectiveness evaluation. CONCLUSIONS: Translation of efficacious findings at the individual level to effectiveness at the population level requires recognition of risk heterogeneity. Recognizing the nuances of working with key populations is essential to ensure that individuals are represented by design and therefore gains in population health can be achieved.
Authors: Kate Shannon; Steffanie A Strathdee; Jean Shoveller; Melanie Rusch; Thomas Kerr; Mark W Tyndall Journal: Am J Public Health Date: 2009-02-05 Impact factor: 9.308
Authors: Sheree R Schwartz; Rebecca G Nowak; Ifeanyi Orazulike; Babajide Keshinro; Julie Ake; Sara Kennedy; Ogbonnaya Njoku; William A Blattner; Manhattan E Charurat; Stefan D Baral Journal: Lancet HIV Date: 2015-07 Impact factor: 12.767
Authors: Stefan D Baral; Andrea Wirtz; Frangiscos Sifakis; Benjamin Johns; Damian Walker; Chris Beyrer Journal: Public Health Rep Date: 2012 Nov-Dec Impact factor: 2.792
Authors: Barrot H Lambdin; Ben Cheng; Trevor Peter; Jessie Mbwambo; Tsitsi Apollo; Megan Dunbar; Ifeoma C Udoh; Adithya Cattamanchi; Elvin H Geng; Paul Volberding Journal: Curr HIV Res Date: 2015 Impact factor: 1.581
Authors: Katherine Rucinski; Louis Masankha Banda; Oluwasolape Olawore; Chris Akolo; Allison Zakaliya; David Chilongozi; Sheree Schwartz; Rose Wilcher; Navindra Persaud; Melchiade Ruberintwari; Stefan Baral Journal: Open Forum Infect Dis Date: 2022-03-07 Impact factor: 3.835